 | Up a level |
Boyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial. Lancet Resp. Med., 2 (7). S. 527 - 539. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600
Rowe, Steven M., McColley, Susanna A., Rietschel, Ernst, Li, Xiaolei, Bell, Scott C., Konstan, Michael W., Marigowda, Gautham, Waltz, David and Boyle, Michael P. (2017). Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR. Ann. Am. Thoracic Society, 14 (2). S. 213 - 220. NEW YORK: AMER THORACIC SOC. ISSN 2325-6621